Atlas Trials

A Clinical Study to Evaluate the Safety and Tolerability of JS001sc in Advanced Nasopharyngeal Carcinoma

Clinical trial NCT05751486 · COMPLETED

Trial details

NCT number
NCT05751486
Sponsor
Shanghai Junshi Bioscience Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Advanced Nasopharyngeal Carcinoma
Start date
2022-11-16
Primary completion
2023-12-30
Enrollment
64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.